Events2Join

Why Weight|Loss Drugs Are Billion|Dollar Blockbusters


Pfizer moves forward with weight-loss GLP-1 pill—a needle-free ...

Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 ...

How to Profit from America's $20 Billion Waistline War

Want to know how to profit from the $20 billion weight loss industry? Find safe and effective drugs to back. Here's one very promising pick.

The Ozempic effect: How a weight loss wonder drug gobbled up an ...

There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They've won over the rich and famous, ...

World's Bestselling Drugs Addicted to Broken U.S. Healthcare System

The Anti-Blockbuster: Due to an accounting quirk, Paxlovid from Pfizer (sales rank: 126) had full-year 2023 revenue of negative $1.289 billion in the United ...

Big pharma's blockbuster obesity drug battle is just getting started ...

In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are the undisputed heavyweights in the prizefight for control ...

Pharma, don't abandon the blockbuster drug model just yet - ZS

The myth of the disappearing blockbuster drug · Around 75% of products anticipated to launch between 2017 and 2019, based on consensus forecasts, ...

GLP-1 obesity drugs to reshape pharma landscape

But a perhaps under-appreciated reality is that the GLP-1 obesity drugs are poised to drive record overall prescription drug sales growth and ...

Hollywood's blockbuster weight loss drugs are becoming all the ...

Reuters Ozempic and Wegovy from Novo Nordisk and Eli Lilly's Mounjaro are a new set of drugs that cause weight loss by mimicking a natural ...

Pipeline Report 2023: Game on for blockbusters, novel MOAs and ...

Already marketed for diabetes, the drug could hit $14 billion ... Administrative and safety similarities to Wegovy, combined with larger weight- ...

Weight-Loss Drugs Bring in Even More Money Than Expected (1)

Billion-dollar-plus hauls lift Novo and Lilly's earnings; Both company's revenues shot up nearly 40% this quarter. Weight-loss drugs have ...

Pharmaceutical blockbusters: the past, present, and future(?)

One of the uncomfortable truths about the pharmaceutical industry is that most approved drugs (~55%) don't make enough money to recoup their ...

Multi-billion dollar weight loss drug market causes race to pharmacy

Multi-billion dollar weight loss drug market causes race to pharmacy.

GLP-1 drugs are transforming diabetes, obesity and more. Could a ...

These blockbuster drugs didn't appear overnight. ... Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma.

What will be the biggest selling drug of all-time? - Ted Alexander

We weigh the latest blockbuster weight-loss drugs against pharmaceuticals (and others) that have gone before. ... billion more for weight loss ...

Novo CEO, Sanders to Face Off Over US Prices for Ozempic and ...

... blockbusters, in a high-profile showdown with Sen. Bernie ... weight-loss drugs they desperately need.” Lilly's Zepbound is also ...

Lilly's fortunes rise on back-to-back success for Alzheimer's, obesity ...

The company's market value now exceeds $400 billion, boosted by the strength of trial data for medicines that Wall Street sees as ...

Drugs to Watch: 15 Potential Blockbuster Drugs in 2023 - Drug Topics

Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.

Novo's Main Ozempic Plant Cited for Quality Lapses by FDA

... weight-loss drugs. Photographer: Nanna Navntoft/Bloomberg (Nanna Navntoft/Bloomberg). (Bloomberg) -- Novo Nordisk A/S was cited for quality ...

Why do analysts expect the weight loss drug market to be worth ...

Why do analysts expect the weight loss drug market to be worth $100 billion by the end of the decade? All related (34).

Blockbuster weight loss drugs Ozempic and Wegovy cost Americans ...

Overweight Americans are paying at least double—and up to 10 times more—for blockbuster drugs to help them shed unwanted pounds, ...